Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon initiated a voluntary recall of its Echelon Flex Endopath 60mm staplers across seven different European countries due to potentially malformed staples. The company identified the possibility that some Echelon Flex Endopath staplers may contain an out-of-specification anvil component within the jaw of the device. The issue could lead to malformed […]
Ethicon
West Virginia AG sues Johnson & Johnson over pelvic mesh
West Virginia attorney general Patrick Morrisey yesterday became the latest state AG to sue Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon over its pelvic mesh products. The newest complaint, filed Sept. 18 in the Monongalia County Circuit Court, alleges that Ethicon’s “unlawful, unfair and deceptive marketing of polypropylene mesh products” concealed the potential risks of pelvic […]
First state AG suit over pelvic mesh heads to trial
The first lawsuit filed by a state attorney general, California’s Xavier Becerra, over pelvic mesh products went to trial yesterday in San Diego. The lawsuit alleges that Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon concealed the potential risks of pelvic mesh from the public and physicians. It’s the first of several lawsuits brought by state AGs […]
ITC takes up Johnson & Johnson complaint against Intuitive Surgical
The U.S. International Trade Commission this week voted to launch an investigation into Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon‘s complaint that Intuitive Surgical (NSDQ:ISRG) is importing surgical stapler cartridges from Mexico that allegedly infringe a quintet of Ethicon patents. In a complaint filed with the ITC May 30, Ethicon accused Intuitive’s EndoWrist and SureForm endocutters of infringing five […]
Johnson & Johnson unit loses 9th pelvic mesh case in Philly
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon last week reportedly lost the ninth of eleven product liability lawsuits brought before a Pennsylvania state court when the jury awarded $500,000 in damages to the plaintiff. In handing down the July 28 verdict for Linda Dunfee and her husband Thomas Dunfee, the jury in the Philadelphia County Court […]
J&J’s Ethicon wins clearance for devices to deliver Grifols surgical sealant
Johnson & Johnson’s Ethicon has won FDA clearance for airless spray devices to deliver Grifols’ fibrin sealant to stop surgical bleeding, the companies announced today. The Vistaseal fibrin sealant will be the first product Grifols (NSDQ:GRFS) is introducing with Johnson & Johnson (NYSE:JNJ) and Ethicon as part of a global partnership. Get the full story on our […]
J&J’s Ethicon files ITC complaint against Intuitive Surgical
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon wants the U.S. International Trade Commission to stop Intuitive Surgical (NSDQ:ISRG) from importing robot-assisted surgical staplers it makes in Mexico, alleging that they infringe a quintet of Ethicon patents. In a complaint filed with the ITC last week, Ethicon accused Intuitive’s EndoWrist and SureForm endocutters of infringing five of its […]
Report: J&J faces uphill battle in $20 million pelvic mesh appeal
Johnson & Johnson (NYSE:JNJ) is appealing a $20 million verdict in a 2018 Indiana pelvic mesh trial, but a federal appeals court panel pushed back against the device maker’s argument this week, according to a published report. J&J’s Ethicon subsidiary claims it was wrongly barred from presenting evidence from the FDA saying that its Prolift pelvic […]
J&J ordered to pay $80 million in Pennsylvania pelvic mesh case
A Philadelphia jury has awarded a woman $80 million for injuries caused by pelvic mesh manufactured by Johnson & Johnson’s Ethicon subsidiary, according to media reports. The award includes $50 million in punitive damages and $30 million in compensatory damages — the largest compensatory damages verdict to date in a pelvic mesh case, a company […]
FDA labels Ethicon stapler recall as Class I
The FDA today labeled a select recall of Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon’s Endo-Surgery endoscopic and non-endoscopic curved intraluminal staplers with adjustable height staples as Class I. Class I designations, the FDA’s most severe, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The affected staplers […]
J&J’s Ethicon buys Takeda’s TachoSil fibrin patch for $400m
Takeda Pharmaceutical (TSE:4502;NYSE:TAK) said yesterday that it’s dealing its TachSil fibrin patch to Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon for $400 million in cash. The Japanese company, which is still digesting last year’s $62 billion acquisition of Shire, said it also agreed to sell its Xiidra lifitegrast ophthalmic solution to Novartis (NYSE:NVS) for $3.4 billion, […]